Iovance Biotherapeutics Inc. (IOVA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Iovance Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$14.81
+1.58% today
Market cap
$6.6B
Overall quality
—
Kronos AI 30-day
−64.0%
0 of 8 simulated paths end higher
Iovance Biotherapeutics Inc. (IOVA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $6.6B. It trades at $14.81, up 1.58% today. 10 analysts' average target of $14.40 implies −2.8% from today's price. Kronos AI's 30-day forecast is −64.0% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.40 |
| Low – high | $7.00 – $20.00 |
| Analysts | 10 |
| Upside to average | −2.8% |
Kronos AI 30-day forecast
| Expected close | $5.24 (−64.0%) |
| Likely range | −74.1% … −50.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.